EN
抗体药类似物
Research Grade Trastuzumab
All
TD-HY286016_1.jpg
TD-HY286016_2.jpg
  • CatalogTD-HY286016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • Synonymstimigutuzumab,4D5-8,4D5V8,Herceptin,rhuMabHER2,CAS:180288-69-1
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Trastuzumab


Catalog No. TD-HY286016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target p185erbB2, HER2, NGL, Tyrosine kinase-type cell surface receptor HER2, NEU, MLN 19, Proto-oncogene Neu, MLN19, ERBB2, Proto-oncogene c-ErbB-2, CD340, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P04626
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names timigutuzumab,4D5-8,4D5V8,Herceptin,rhuMabHER2,CAS:180288-69-1
Background Trastuzumab is a humanized IgG1 monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY286016_1.jpg
Bioactivity
 
Detects Human ERBB2 in indirect ELISAs.
TD-HY286016_2.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Trastuzumab.